Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting

Eur J Vasc Endovasc Surg. 2014 Jul;48(1):105-6. doi: 10.1016/j.ejvs.2014.03.009. Epub 2014 Apr 13.

Authors

A D Giannoukas¹, K I Paraskevas², R Bulbulia³, A Halliday³

Affiliations

¹ Department of Vascular Surgery, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece. Electronic address: [email protected].
² Department of Vascular Surgery, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
³ Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.

PMID: 24735779
DOI: 10.1016/j.ejvs.2014.03.009

No abstract available

Publication types

Letter

MeSH terms

Angioplasty / adverse effects
Angioplasty / instrumentation*
Carotid Artery Diseases / complications
Carotid Artery Diseases / diagnosis
Carotid Artery Diseases / therapy*
Clinical Trials as Topic / methods*
Endarterectomy, Carotid* / adverse effects
Endpoint Determination
Humans
Intracranial Embolism / diagnosis
Intracranial Embolism / etiology
Intracranial Embolism / prevention & control*
Research Design*
Stents*
Treatment Outcome
Vision Disorders / diagnosis
Vision Disorders / etiology
Vision Disorders / prevention & control*

Grants and funding

06/301/233/DH_/Department of Health/United Kingdom